Overweight and Obesity Epidemiology Analysis and Forecast to 2031
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Overweight and Obesity Epidemiology Analysis Report Overview
The combined diagnosed prevalent cases of overweight and obesity were 276,919,516 in the seven major markets (7MM) in 2021. Changes in the total and diagnosed prevalent cases of overweight and obesity throughout the forecast can be attributed to both increasing disease prevalence and the population dynamics in each market.
Some heritable traits predispose individuals to obesity, but most factors leading to its onset are behavioral. The widening prevalence of unhealthy diets and sedentary lifestyles may lead to excess caloric intake, leading to an accumulation of body fat, and thus obesity. Medical conditions, medications, and genetic factors that disrupt metabolism and endocrine function may predispose certain individuals to weight gain as well. Physicians most often recommend dietary changes and increased physical activity to treat obesity. Clinical practice favors conservative treatment options relying on behavioral modification for patients with Class I and Class II obesity.
Overweight and Obesity Market Outlook, 2021-2031 (Diagnosed Prevalent Cases)
To gain more information on the overweight and obesity market forecast, download a free report sample
The Overweight and Obesity market research report provides an overview of the risk factors, comorbidities, and global and historical trends for overweight and obesity in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan). The report also features a 10-year epidemiological forecast for the total prevalent cases of overweight and obesity and diagnosed prevalent cases of overweight and obesity segmented by age and sex.
Market Size (2021) | 276,919,516 cases |
Key Age Segments (Overweight and Obesity) | 5-9 years, 10-19 years, 20-29 years, 30-39 years, 40-49 years, 50-59 years, 60-69 years, 70-79 years, and above 80 years |
Key Sex Segments (Overweight and Obesity) | Men and Women |
Overweight and Obesity Market Segmentation by Age
The overweight and obesity market can be segmented based on age into 5-9 years, 10-19 years, 20-29 years, 30-39 years, 40-49 years, 50-59 years, 60-69 years, 70-79 years, and above 80 years.
In 2021, for the 7MM combined, the 50–59-year age group constituted the highest proportion of diagnosed prevalent cases of overweight, followed by the age group 40–49 years and ages 60-69 years.
In 2021, for the 7MM combined, the 50–59-year age group represented the highest number of diagnosed prevalent cases of obesity. The lowest proportion of diagnosed prevalent cases in the 7MM was among the 5–9-year age group.
Overweight Market Analysis by Age, 2021 (%)
For more age segment insights into the overweight and obesity market, download a free report sample
Overweight and Obesity Market Segmentation by Sex
The overweight and obesity market can be segmented based on sex into men and women.
In 2021, the number of diagnosed prevalent cases of overweight was higher in men than women. Similarly, more of the diagnosed prevalent cases of overweight were men across every market.
In 2021, the number of diagnosed prevalent cases of obesity was almost evenly distributed between men and women in the 7MM. Of the 7MM, Japan had the largest difference in the diagnosed prevalent cases of obesity between women and men.
Overweight Market Analysis by Sex, 2021 (%)
For more sex segment insights into the overweight and obesity market, download a free report sample
Segments Covered in the Report
Overweight and Obesity Market Age Outlook (Diagnosed Prevalent Cases, 2021-2031)
- 5-9 years
- 10-19 years
- 20-29 years
- 30-39 years
- 40-49 years
- 50-59 years
- 60-69 years
- 70-79 years
- Above 80 years
Overweight and Obesity Market Sex Outlook (Diagnosed Prevalent Cases, 2021-2031)
- Men
- Women
Scope
- The Epidemiology Report provides an expert analysis of disease trends in the 7MM.
- The Epidemiology Model is easy to navigate, interactive with dashboards, and epidemiology-based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over a 10-year forecast period using reputable sources.
Reasons to Buy
The overweight and obesity epidemiology series will allow you to:
- Develop business strategies by understanding the trends shaping and driving the global overweight and obese markets.
- Quantify patient populations in the global overweight and obese markets to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for overweight and obesity therapeutics in each of the markets covered.
- Understand the magnitude of the overweight and obese population by age, sex, and BMI class.
Table of Contents
Table
Figures
Frequently asked questions
-
What was the total number of diagnosed prevalent cases of overweight and obesity in the 7MM 2021?
The combined diagnosed prevalent cases of overweight and obesity was 276,919,516 in the seven major markets (7MM) in 2021.
-
What are the most common contributors to obesity?
The most common contributors to obesity are excess caloric intake and low physical activity.
-
What are the key age segments in the overweight and obesity market?
The key age segments in the overweight and obesity market are 5-9 years, 10-19 years, 20-29 years, 30-39 years, 40-49 years, 50-59 years, 60-69 years, 70-79 years, and above 80 years.
-
What are the key sex segments in the overweight and obesity market?
The overweight and obesity market can be segmented based on sex into men and women.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.